Celldex Therapeutics, Inc vs. Myriad Genetics Inc
Celldex Therapeutics, Inc (CLDX) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| CLDX | MYGN | |
|---|---|---|
| Market Cap | $2.35 billion | $634.16 million |
CLDX leads on 1 of 1 size & scale factors.
Risk & Sentiment
| CLDX | MYGN | |
|---|---|---|
| Short Interest | 9.28% | 13.76% |
CLDX leads on 1 of 1 risk & sentiment factors.
Dig deeper: CLDX overview, CLDX financials, MYGN overview, MYGN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.